Patients with relapsed and refractory HL have an increased chance of cure with HDT and ASCT, which can be estimated at approximately 50-60%. All outcomes are better in late relapses and if ...

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of progression-free (PFS) and overall survival (OS) at 3-5 years ...

And for many people with these cancers, like Laura, relapse scenarios are all too familiar. But treatment options for NHL are on the rise. Rising rates of non-Hodgkin's lymphoma in the U.S. are ...

Hodgkin's lymphoma is a type of cancer that affects the lymphatic system, which is part of the body's immune system that fights disease and germs. "Yesterday I was informed that I have relapsed ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

Non-Hodgkin’s lymphoma (NHL) is a cancer found in white blood cells called lymphocytes. After diagnosis, your doctor can stage your NHL. Staging helps determine how far the cancer has spread and ...

Non-Hodgkin’s lymphoma (NHL) has several subtypes with ... about a person’s outlook and life expectancy, their chance of relapse, and more. NHL is a group of blood cancers that have similar ...